News

A compelling session at the EHA Congress explored how space research is reshaping our understanding of hematologic processes.
Researchers discovered a previously unknown function of RNA, potentially opening the door to new ways to treat cancer and ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.11, a high estimate of $68.00, ...
New research reveals that Gαi3 is overexpressed in bladder cancer and promotes tumour growth via the Akt-mTOR pathway, highlighting its potential as a therapeutic target.
Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...
Turning a $10,000 investment into $1 million represents a financial dream for many — a 100x return that would require an ...
Scientists have developed a new technique to unleash silenced genes and change cell fates using CRISPR/Cas9. The ability to control gene expression in cells allows scientists to understand gene ...
A team at Kobe University has created a game-changing resource for autism research: 63 mouse embryonic stem cell lines, each ...
While commercial uptake by patients still lags and a recent court decision rekindles a legal battle, clinical successes continue.
Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...
Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.